secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-10-24T23:59:59+00:00
Accession:  0001213900-22-065860
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics announces 1-for-25 reverse stock split effective Oct 26 to meet Nasdaq bid price requirement
--------------------------------------------------------------------------------

- Reverse stock split at 1:25 ratio becomes effective pre-market on October 26, 2022.
- Post-split shares outstanding approximately 1,288,468; authorized shares reduced to 3,000,000.
- Common stock continues trading under symbol "HOTH" with new CUSIP 44148G 204.
- Fractional shares rounded up to next whole share; no par value change.
- Split intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022065860/0001213900-22-065860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022065860/ea167441-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-065860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer